StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

Equities research analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a note issued to investors on Saturday. The firm set a “hold” rating on the stock.

Separately, Benchmark reaffirmed a “speculative buy” rating and set a $1.25 target price on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Trading Up 5.4 %

MLSS stock opened at $0.88 on Friday. The business’s 50-day moving average is $0.81 and its 200 day moving average is $0.86. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.10. The stock has a market cap of $68.54 million, a price-to-earnings ratio of -12.57 and a beta of 1.10.

Insiders Place Their Bets

In other news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the sale, the director now owns 4,606,882 shares in the company, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 24.75% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of MLSS. Y Intercept Hong Kong Ltd acquired a new stake in shares of Milestone Scientific during the third quarter valued at about $48,000. Geode Capital Management LLC increased its holdings in Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the last quarter. Finally, World Investment Advisors LLC purchased a new position in shares of Milestone Scientific during the third quarter worth $91,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.